| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| HALOZYME THERAPEUTICS, INC. | Director | Common Stock | 53.6K | $2.06M | $38.49 | Apr 25, 2024 | Direct |
| BECTON DICKINSON & CO | Director | Common Stock | 5.57K | $1.29M | $232.46 | Jan 23, 2024 | Direct |
| QUALCOMM INC/DE | Director | Common Stock | 6.41K | $1.09M | $170.57 | Mar 10, 2024 | Direct |
| QUALCOMM INC/DE | Director | Deferred Stock Unit | 5.73K | $977K | $170.57 | Mar 10, 2024 | Direct |
| HALOZYME THERAPEUTICS, INC. | Director | Option to Purchase Common Stock | 8.8K | $122K | $13.87 | Apr 25, 2024 | Direct |
| FIBROGEN INC | Director | Common Stock | 28.9K | $21.9K | $0.76 | Sep 1, 2023 | Direct |
| BECTON DICKINSON & CO | Director | Common Stock | 15 | $3.49K | $232.46 | Jan 23, 2024 | By wife |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| HALO | HALOZYME THERAPEUTICS, INC. | Apr 25, 2024 | 2 | $0 | 4 | Apr 29, 2024 | Director |
| QCOM | QUALCOMM INC/DE | Mar 10, 2024 | 2 | $0 | 4 | Mar 11, 2024 | Director |
| QCOM | QUALCOMM INC/DE | Mar 5, 2024 | 1 | $0 | 4 | Mar 7, 2024 | Director |
| BDX | BECTON DICKINSON & CO | Jan 23, 2024 | 1 | $0 | 4 | Jan 25, 2024 | Director |
| FGEN | FIBROGEN INC | Sep 1, 2023 | 1 | -$2.06K | 4 | Sep 6, 2023 | Director |
| FGEN | FIBROGEN INC | Aug 4, 2023 | 1 | -$3.82K | 4 | Aug 8, 2023 | Director |
| FGEN | FIBROGEN INC | Jul 11, 2023 | 1 | -$5.38K | 4 | Jul 13, 2023 | Director |
| FGEN | FIBROGEN INC | Jun 7, 2023 | 4 | -$122K | 4 | Jun 9, 2023 | Director |
| HALO | HALOZYME THERAPEUTICS, INC. | May 5, 2023 | 2 | $0 | 4 | May 9, 2023 | Director |
| QCOM | QUALCOMM INC/DE | Mar 10, 2023 | 3 | -$123K | 4 | Mar 13, 2023 | Director |
| QCOM | QUALCOMM INC/DE | Mar 8, 2023 | 1 | $0 | 4 | Mar 10, 2023 | Director |
| HALO | HALOZYME THERAPEUTICS, INC. | Feb 28, 2023 | 2 | -$962K | 4 | Mar 1, 2023 | Director |
| QCOM | QUALCOMM INC/DE | Feb 22, 2023 | 2 | -$621K | 4 | Feb 24, 2023 | Director |
| BDX | BECTON DICKINSON & CO | Jan 24, 2023 | 1 | $0 | 4 | Jan 26, 2023 | Director |
| FGEN | FIBROGEN INC | Jun 16, 2022 | 2 | $0 | 4 | Jun 21, 2022 | Director |
| HALO | HALOZYME THERAPEUTICS, INC. | May 5, 2022 | 1 | $0 | 4 | May 6, 2022 | Director |
| QCOM | QUALCOMM INC/DE | Mar 12, 2022 | 3 | -$224K | 4 | Mar 15, 2022 | Director |
| QCOM | QUALCOMM INC/DE | Mar 9, 2022 | 1 | $0 | 4 | Mar 11, 2022 | Director |
| BDX | BECTON DICKINSON & CO | Jan 25, 2022 | 1 | $0 | 4 | Jan 26, 2022 | Director |
| FGEN | FIBROGEN INC | May 26, 2021 | 2 | $0 | 4 | May 28, 2021 | Director |